PRN: Global Preventive Vaccines Market (2014-2019) - Key Vendors are Sanofi Avnetis, Merck, Glaxosmithkline, Novartis, Pfizer & Serum Institute

The report estimates that close to 120 new vaccines in the pipeline of various companies across the globe set to hit the market during the forecasted period.

Persone Laura Wood, Once
Luoghi Dublino
Organizzazioni Key Topics Covered, Sanofi Avnetis Merck Glaxosmithkline Novartis Pfizer Serum, Global Preventive Vaccines Market, Pfizer & Serum Institute
Argomenti commercio, economia

15/gen/2016 16.46.27 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Global Preventive Vaccines Market (2014-2019) - Key Vendors are Sanofi Avnetis, Merck, Glaxosmithkline, Novartis, Pfizer & Serum Institute

 
[15-January-2016]
 

DUBLIN, Jan. 15, 2016 /PRNewswire/ -- 

Research and Markets (http://www.researchandmarkets.com/research/xtgtp9/global_preventive) has announced the addition of the "Global Preventive Vaccines Market- Trends and Forecasts (2014-2019)" report to their offering.

The report estimates that close to 120 new vaccines in the pipeline of various companies across the globe set to hit the market during the forecasted period. With this in mind, the report expects the global vaccine market to grow at a CAGR of close to 12.4% until the year 2020.

There has been rapid growth in the market in recent years, with the market quadrupling in value from $5 billion in 2000 to $24 billion in 2013. Once a commodity market with low margins, the vaccines on the market now include blockbusters and mega blockbusters.

New candidates for vaccination against cancers and HIV which are under development are also projected to hit the magical milestone. Multinational vaccine companies historically have conducted much of the innovation, research, and development in the field of vaccine production.

They have used significant revenues, global size, and deeper expertise to fund these R&D efforts. New technologies are also being introduced to curb the time and expense incurred for new vaccine discovery and production. But despite the success of vaccines, infectious diseases are still a major cause of illnesses worldwide and at least 40 major infectious diseases are still uncontrolled by vaccination.

Key Vendors:

  • Sanofi Avnetis
  • Merck
  • Glaxosmithkline
  • Novartis
  • Pfizer
  • Serum institute

Key Topics Covered:

1. Introduction

2. Executive Summary

3. Global Therapeutic Proteins Market - Industry Analysis

4. Types of Vaccines

5. Vaccine market by application

6. Regional Analysis of the Vaccine market

7. Competitive Landscape

8. Key Company Profiles

For more information visit http://www.researchandmarkets.com/research/xtgtp9/global_preventive

Media Contact:

Laura Wood , +353-1-481-1716, press@researchandmarkets.net

 

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl